HealthcareServices

Vaccine Technologies Industry Growth Insights: Revenue Forecast to 2030

March 3, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the vaccine technologies market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Vaccine Technologies Market between 2026 and 2030?

The vaccine technologies market has experienced significant expansion recently. Its size is expected to increase from $61.38 billion in 2025 to $67.71 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. This historical development can be attributed to several factors, including the expansion of national immunization initiatives, augmented public health funding, breakthroughs in vaccine production technologies, an increase in infectious disease surveillance, and the establishment of global vaccine supply chains.

The vaccine technologies market is projected to experience substantial growth in the upcoming years, reaching $99.04 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.0%. This anticipated expansion throughout the forecast period stems from factors such as heightened investments in advanced vaccine platforms, a growing need for pandemic readiness strategies, the broadening scope of adult vaccination initiatives, increased attention on vaccines for non-infectious diseases, and the wider implementation of digital systems for vaccine tracking. Key trends anticipated during this period encompass the accelerated development of mRNA and recombinant vaccines, an intensified focus on platforms for rapid vaccine production, the increasing adoption of innovative delivery technologies, the expansion of worldwide immunization programs, and a greater emphasis on optimizing cold chain logistics.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24735&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Vaccine Technologies Market?

The escalating occurrence of infectious diseases is anticipated to boost the expansion of the vaccine technologies market moving forward. These diseases are defined as illnesses caused by detrimental microorganisms such as bacteria, viruses, fungi, or parasites, capable of spreading directly or indirectly between people. The uptick in infectious disease prevalence is attributed to increased global travel, which facilitates the swift dissemination of pathogens internationally. Vaccine technologies play a crucial role in treating infectious diseases by stimulating targeted immune responses, thereby aiding in the prevention and control of infections. They also reinforce public health endeavors by reducing the spread and severity of diseases, thus improving overall healthcare outcomes. For example, in February 2024, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis (a contagious bacterial infection primarily affecting the lungs) cases in England climbed to 4,850 in 2023, representing a 10.7% increase from the 4,380 cases observed in 2022. Hence, the rising prevalence of infectious diseases is a key driver for the growth of the vaccine technologies market.

How Is The Vaccine Technologies Market Organized Into Various Segments?

The vaccine technologies market covered in this report is segmented –

1) By Type: Recombinant Or Conjugate Or Subunit, Inactivated, Live Attenuated, Toxoid

2) By Route Of Administration: Parenteral, Oral, Nasal

3) By Disease Indication: Infectious Diseases, Non-Infectious Diseases

4) By Age Group: Pediatric, Adults

5) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Distribution Channels

Subsegments:

1) By Recombinant Or Conjugate Or Subunit: Protein Subunit Vaccines, Virus-Like Particle (VLP) Vaccines, Glycoconjugate Vaccines, Recombinant Vector Vaccines

2) By Inactivated: Whole-Virus Inactivated Vaccines, Split-Virus Inactivated Vaccines, Purified Inactivated Vaccines

3) By Live Attenuated: Viral Live Attenuated Vaccines, Bacterial Live Attenuated Vaccines

4) By Toxoid: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines

What Trends Are Driving The Growth Trajectory Of The Vaccine Technologies Market?

Key players within the vaccine technologies market are actively pursuing the creation of advanced solutions, specifically quadrivalent influenza vaccines, aimed at delivering more extensive immunization and mitigating the potential for strain discrepancies. These quadrivalent vaccines are specifically designed to safeguard against four distinct influenza virus strains, comprising two influenza A and two influenza B viruses, thereby providing superior protection compared to trivalent alternatives. An illustrative example occurred in February 2025, when Zydus Lifesciences, an India-based pharmaceutical firm, introduced VaxiFlu-4, which is a quadrivalent influenza vaccine. This vaccine delivers seasonal immunity against four influenza strains, encompassing both influenza A and B varieties, and is administered via a single-dose intramuscular injection, making it appropriate for both adult and pediatric populations. Its broader strain coverage, when contrasted with conventional trivalent vaccines, contributes to lessening the impact of seasonal influenza.

Who Are The Top-Performing Companies In The Vaccine Technologies Market In Recent Years?

Major companies operating in the vaccine technologies market are Pfizer Inc, Johnson And Johnson, Merck And Co Inc, Sanofi SA, AstraZeneca Plc, GSK Plc, Moderna Inc, CSL Limited, Bharat Biotech International Limited, Bavarian Nordic AS, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd, Emergent BioSolutions Inc, Valneva SE, Novavax Inc, Dynavax Technologies Corporation, CureVac NV, Inovio Pharmaceuticals Inc, Serum Institute Of India Pvt Ltd, BioNTech SE, Panacea Biotec Ltd, Biological E Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/vaccine-technologies-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Vaccine Technologies Market?

North America was the largest region in the vaccine technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Vaccine Technologies Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24735&type=smp

Browse Through More Reports Similar to the Global Vaccine Technologies Market 2026, By The Business Research Company

Dog Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Swine Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Typhoid Vi Polysaccharide Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795